These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28225333)

  • 1. Why do clinical trials of Xpert® MTB/RIF fail to show an effect on patient relevant outcomes?
    Boyles TH
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):249-250. PubMed ID: 28225333
    [No Abstract]   [Full Text] [Related]  

  • 2. Initial screening of extra-pulmonary tuberculosis using the Xpert MTB/RIF assay improves case detection rates.
    Jain A; Singh PK; Singh U; Kumar V
    Int J Tuberc Lung Dis; 2017 Apr; 21(4):478-480. PubMed ID: 28284274
    [No Abstract]   [Full Text] [Related]  

  • 3. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
    Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
    Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues.
    Polepole P; Kabwe M; Kasonde M; Tembo J; Shibemba A; O'Grady J; Kapata N; Zumla A; Bates M
    Int J Mycobacteriol; 2017; 6(1):87-93. PubMed ID: 28317811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microscopic observation drug-susceptibility assay vs. Xpert
    Wikman-Jorgensen PE; Llenas-García J; Pérez-Porcuna TM; Hobbins M; Ehmer J; Mussa MA; Ascaso C
    Trop Med Int Health; 2017 Jun; 22(6):734-743. PubMed ID: 28380276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xpert MTB/RIF test for tuberculosis.
    Salvo F; Sadutshang TD; Migliori GB; Zumla A; Cirillo DM
    Lancet; 2011 Aug; 378(9790):481-2; author reply 482-3. PubMed ID: 21821177
    [No Abstract]   [Full Text] [Related]  

  • 7. Xpert MTB/RIF test for tuberculosis.
    Theron G; Peter J; Dheda K
    Lancet; 2011 Aug; 378(9790):481; author reply 482-3. PubMed ID: 21821176
    [No Abstract]   [Full Text] [Related]  

  • 8. Coverage and fidelity of the Xpert MTB/RIF™ implementation in a high-burden area for pulmonary tuberculosis in Colombia.
    Agredo F; Osorio L
    Biomedica; 2020 Dec; 40(4):626-640. PubMed ID: 33275342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xpert MTB/RIF test for tuberculosis.
    Ferrara G; O'Grady J; Zumla A; Maeurer M
    Lancet; 2011 Aug; 378(9790):482; author reply 482-3. PubMed ID: 21821179
    [No Abstract]   [Full Text] [Related]  

  • 10. False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load.
    Ocheretina O; Byrt E; Mabou MM; Royal-Mardi G; Merveille YM; Rouzier V; Fitzgerald DW; Pape JW
    Diagn Microbiol Infect Dis; 2016 May; 85(1):53-5. PubMed ID: 26915638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness study of the microbiological diagnosis of tuberculosis using geneXpert MTB/RIF
    Herráez Ó; Asencio-Egea MÁ; Huertas-Vaquero M; Carranza-González R; Castellanos-Monedero J; Franco-Huerta M; Barberá-Farré JR; Tenías-Burillo JM
    Enferm Infecc Microbiol Clin; 2017; 35(7):403-410. PubMed ID: 27445177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampicin Resistant Tuberculosis in Lesotho: Diagnosis, Treatment Initiation and Outcomes.
    Katende B; Esterhuizen TM; Dippenaar A; Warren RM
    Sci Rep; 2020 Feb; 10(1):1917. PubMed ID: 32024860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnosis of extrapulmonary tuberculosis and sensitivity to rifampicin with an automated real-time method.
    Peñata A; Salazar R; Castaño T; Bustamante J; Ospina S
    Biomedica; 2016 Feb; 36(0):78-89. PubMed ID: 27622628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications.
    Van Rie A; Mellet K; John MA; Scott L; Page-Shipp L; Dansey H; Victor T; Warren R
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):206-8. PubMed ID: 22236921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xpert MTB/RIF - why the lack of morbidity and mortality impact in intervention trials?
    Auld AF; Fielding KL; Gupta-Wright A; Lawn SD
    Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):432-44. PubMed ID: 27638038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application value of Xpert MTB/RIF in diagnosis of spinal tuberculosis and detection of rifampin resistance].
    Jin YH; Shi SY; Zheng Q; Shen J; Ying XZ; Wang YF
    Zhongguo Gu Shang; 2017 Sep; 30(9):787-791. PubMed ID: 29455477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland.
    Sanchez-Padilla E; Merker M; Beckert P; Jochims F; Dlamini T; Kahn P; Bonnet M; Niemann S
    N Engl J Med; 2015 Mar; 372(12):1181-2. PubMed ID: 25785984
    [No Abstract]   [Full Text] [Related]  

  • 19. Detecting drug-resistant tuberculosis: beacons in the dark.
    Bialy H
    Nat Biotechnol; 1998 Apr; 16(4):331. PubMed ID: 9555717
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of the Xpert(®) MTB/RIF and GenoType(®) MTBDRplus assays in Georgia.
    Bablishvili N; Tukvadze N; Avaliani Z; Blumberg HM; Kempker RR
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):676-8. PubMed ID: 25946358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.